Barbara Schwierin

Results of European post-marketing surveillance of bosentan in pulmonary hypertension

Marc Humbert, Eleanor S Segal, David G. Kiely et al. · European Respiratory Journal · 2007 · 295 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Disease and patient characteristics in NP-C patients: findings from an international disease registry

Marc C. Patterson, Eugen Mengel, Frits A. Wijburg et al. · Orphanet Journal of Rare Diseases · 2013 · 197 citations · Full text

Medicine, Clinical Sciences, Neurology +14

Selective and total sleep deprivation: effect on the sleep EEG in the rat

Takuro Endo, Barbara Schwierin, Alexander A. Borbély et al. · Psychiatry Research · 1997 · 130 citations

Life Sciences, Neurobiology, Neuroscience +13

Effects of N6-cyclopentyladenosine and caffeine on sleep regulation in the rat

Barbara Schwierin, Alexander A. Borbély, Irene Tobler · European Journal of Pharmacology · 1996 · 129 citations

Life Sciences, Neuroscience, Pharmacology +10

Safety Experience With Bosentan in 146 Children 2–11 Years Old With Pulmonary Arterial Hypertension: Results from the European Postmarketing Surveillance Program

Maurice Beghetti, Marius M. Hoeper, David G. Kiely et al. · Pediatric Research · 2008 · 109 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +12